Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: £2.03 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	£26.96 M	£86.01 M	🇺🇸 USA
Geron GERN	£0.23 M	£9.7 M	🇺🇸 USA
Omeros Corporation OMER	£4.83 M	£15.63 M	🇺🇸 USA
Sanofi SNY	£9.04 M	£67.5 M	🇫🇷 France
Bio-Techne TECH	£5.59 M	£14.08 M	🇺🇸 USA
Genetic Technologies GENE	N/A	£0 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	£3.35 M	£38.2 M	🇮🇱 Israel